Laprophan raises $223m in Africa’s largest Pharma IPO
What do you make of it?
Read the story
The Moroccan firm sold 6.52m existing and new shares at 341 dirhams each, valuing it at about 5.9 billion dirhams.
The Moroccan firm sold 6.52m existing and new shares at 341 dirhams each, valuing it at about 5.9 billion dirhams.